CVNov 20, 2023
MGCT: Mutual-Guided Cross-Modality Transformer for Survival Outcome Prediction using Integrative Histopathology-Genomic FeaturesMingxin Liu, Yunzan Liu, Hui Cui et al.
The rapidly emerging field of deep learning-based computational pathology has shown promising results in utilizing whole slide images (WSIs) to objectively prognosticate cancer patients. However, most prognostic methods are currently limited to either histopathology or genomics alone, which inevitably reduces their potential to accurately predict patient prognosis. Whereas integrating WSIs and genomic features presents three main challenges: (1) the enormous heterogeneity of gigapixel WSIs which can reach sizes as large as 150,000x150,000 pixels; (2) the absence of a spatially corresponding relationship between histopathology images and genomic molecular data; and (3) the existing early, late, and intermediate multimodal feature fusion strategies struggle to capture the explicit interactions between WSIs and genomics. To ameliorate these issues, we propose the Mutual-Guided Cross-Modality Transformer (MGCT), a weakly-supervised, attention-based multimodal learning framework that can combine histology features and genomic features to model the genotype-phenotype interactions within the tumor microenvironment. To validate the effectiveness of MGCT, we conduct experiments using nearly 3,600 gigapixel WSIs across five different cancer types sourced from The Cancer Genome Atlas (TCGA). Extensive experimental results consistently emphasize that MGCT outperforms the state-of-the-art (SOTA) methods.
IVFeb 8, 2024
Unleashing the Infinity Power of Geometry: A Novel Geometry-Aware Transformer (GOAT) for Whole Slide Histopathology Image AnalysisMingxin Liu, Yunzan Liu, Pengbo Xu et al.
The histopathology analysis is of great significance for the diagnosis and prognosis of cancers, however, it has great challenges due to the enormous heterogeneity of gigapixel whole slide images (WSIs) and the intricate representation of pathological features. However, recent methods have not adequately exploited geometrical representation in WSIs which is significant in disease diagnosis. Therefore, we proposed a novel weakly-supervised framework, Geometry-Aware Transformer (GOAT), in which we urge the model to pay attention to the geometric characteristics within the tumor microenvironment which often serve as potent indicators. In addition, a context-aware attention mechanism is designed to extract and enhance the morphological features within WSIs.
IVJul 7, 2025
MurreNet: Modeling Holistic Multimodal Interactions Between Histopathology and Genomic Profiles for Survival PredictionMingxin Liu, Chengfei Cai, Jun Li et al.
Cancer survival prediction requires integrating pathological Whole Slide Images (WSIs) and genomic profiles, a challenging task due to the inherent heterogeneity and the complexity of modeling both inter- and intra-modality interactions. Current methods often employ straightforward fusion strategies for multimodal feature integration, failing to comprehensively capture modality-specific and modality-common interactions, resulting in a limited understanding of multimodal correlations and suboptimal predictive performance. To mitigate these limitations, this paper presents a Multimodal Representation Decoupling Network (MurreNet) to advance cancer survival analysis. Specifically, we first propose a Multimodal Representation Decomposition (MRD) module to explicitly decompose paired input data into modality-specific and modality-shared representations, thereby reducing redundancy between modalities. Furthermore, the disentangled representations are further refined then updated through a novel training regularization strategy that imposes constraints on distributional similarity, difference, and representativeness of modality features. Finally, the augmented multimodal features are integrated into a joint representation via proposed Deep Holistic Orthogonal Fusion (DHOF) strategy. Extensive experiments conducted on six TCGA cancer cohorts demonstrate that our MurreNet achieves state-of-the-art (SOTA) performance in survival prediction.
CVJun 4, 2021
GasHisSDB: A New Gastric Histopathology Image Dataset for Computer Aided Diagnosis of Gastric CancerWeiming Hu, Chen Li, Xiaoyan Li et al.
Background and Objective: Gastric cancer has turned out to be the fifth most common cancer globally, and early detection of gastric cancer is essential to save lives. Histopathological examination of gastric cancer is the gold standard for the diagnosis of gastric cancer. However, computer-aided diagnostic techniques are challenging to evaluate due to the scarcity of publicly available gastric histopathology image datasets. Methods: In this paper, a noble publicly available Gastric Histopathology Sub-size Image Database (GasHisSDB) is published to identify classifiers' performance. Specifically, two types of data are included: normal and abnormal, with a total of 245,196 tissue case images. In order to prove that the methods of different periods in the field of image classification have discrepancies on GasHisSDB, we select a variety of classifiers for evaluation. Seven classical machine learning classifiers, three Convolutional Neural Network classifiers, and a novel transformer-based classifier are selected for testing on image classification tasks. Results: This study performed extensive experiments using traditional machine learning and deep learning methods to prove that the methods of different periods have discrepancies on GasHisSDB. Traditional machine learning achieved the best accuracy rate of 86.08% and a minimum of just 41.12%. The best accuracy of deep learning reached 96.47% and the lowest was 86.21%. Accuracy rates vary significantly across classifiers. Conclusions: To the best of our knowledge, it is the first publicly available gastric cancer histopathology dataset containing a large number of images for weakly supervised learning. We believe that GasHisSDB can attract researchers to explore new algorithms for the automated diagnosis of gastric cancer, which can help physicians and patients in the clinical setting.